ABOUT MBL77

mutations presented The point that, as stated down below, CLL therapy is based about the existence or absence of such mutations. The present consensus is always that, in addition to clonal mutations, subclonal mutations having a variant allelic frequency ranging from five to ten% (and as a consequence beneath the threshold of detection by tradition